Search for: "Astellas Pharma Inc."
Results 1 - 20
of 53
Sorted by Relevance
|
Sort by Date
28 Nov 2007, 8:53 pm
By Sherri Oslick -- Astellas Pharma Inc. of Tokyo, has announced an agreement between its U.S. subsidiary, Astellas U.S. [read post]
26 Nov 2007, 9:02 pm
By Baltazar Gomez -- Last month, Astellas Pharma Inc., King Pharmaceuticals, Inc., and Teva Pharmaceutical Industries Ltd. announced that U.S. subsidiaries of Astellas, along with Item Development AB and King have signed settlement agreements with respect to U.S. [read post]
2 Mar 2010, 4:15 pm
Just hours after announcing a $3.5 billion takeover offer for OSI Pharmaceuticals, Astellas Pharma Inc. filed a lawsuit against its target to block any challenges to the bid. [read post]
20 Apr 2014, 8:26 pm
Astellas Pharma US Inc., located in Northbrook, Ill., manufactures and sells pharmaceutical drugs, including Mycamine [read post]
15 Aug 2023, 4:29 am
Jane LambertCourt of Appeal (Lords Justices Arnold and Stuart-Smith and Lady Justice Falk) Teva Pharmaceutical Industries Ltd and another v Astellas Pharma Inc [2023] EWCA Civ 880 (25 July 2023) This was an appeal against the dismissal of the claim by Teva Pharmaceutical Industries Ltd. and Teva UK Ltd. [read post]
7 Nov 2010, 9:59 pm
Inc. 1:10-cv-08274; filed November 2, 2010 in the Southern District of New York • Plaintiffs: Astellas US LLC; Astellas Pharma Inc. [read post]
7 Feb 2016, 9:59 pm
Astellas Pharma Inc. et al. v. [read post]
3 Jun 2012, 8:34 pm
Hospira Inc. 1:12-cv-00652; filed May 23, 2012 in the District Court of Delaware • Plaintiffs: Astellas US LLC; Astellas Pharma US, Inc.; Item Development AB • Defendant: Hospira Inc. [read post]
5 Feb 2014, 2:16 am
Case C-661/13 Astellas Pharma Inc, a reference for a preliminary ruling to the Court of Justice of the European Union (CJEU) from the Oberlandesgericht Düsseldorf, Germany, came into the IPKat's line of vision in mid-January thanks to katfriend Paul England (see earlier Katpost here). [read post]
8 Nov 2007, 8:01 pm
By Sherri Oslick -- Ranbaxy Laboratories, Astellas Pharma US, Inc., and Boehringer Ingelheim Corporation have announced their agreement to enter into a joint stipulation of dismissal without prejudice in their lawsuit over FLOMAX ® (tamsulosin hydrochloride, used to treat benign prostatic hyperplasia). [read post]
21 May 2010, 2:00 pm
This week's announcement that Japanese drugmaker Astellas Pharma Inc. had finalized its $4 billion acquisition of Melville, N.Y. [read post]
21 Sep 2011, 12:27 pm
Astellas Pharma US Inc., No. 10 C 1539, Slip Op. [read post]
30 Mar 2016, 8:27 am
U.S. lawmakers want prostate cancer drugs lowered, who called on the National Institutes of Health and Human Services to reduce the costs of Xtandi, Medivation Inc’s and Astellas Pharma Inc’s prostate cancer drug. [read post]
9 Aug 2018, 12:08 pm
In 2016 it was purchased by Astellas Pharma of Japan for $379 million. [read post]
24 Feb 2012, 7:02 am
District Court for the District of Massachusetts has denied the motion to dismiss filed in the consolidated class action of In re Prograf Antitrust Litigation by the defendant, organ transplant drug manufacturer Astellas Pharma US, Inc. [read post]
12 Nov 2017, 6:10 pm
Astellas Pharma Inc. [read post]
28 Apr 2020, 11:46 pm
by Olivia Henry and Nicholas Michelmore On 20 April 2020, Arnold LJ (sitting as a High Court Judge) gave judgment in the case between FibroGen Inc and Astellas Pharma Inc (together the “Claimants”), and Akebia Therapeutics Inc and Otsuka Pharmaceutical Company Limited (together the “Defendants”) which concerned six patents owned by FibroGen and exclusively licensed to Astellas (the “Patents”). [read post]
29 Jun 2011, 3:34 am
Sun Pharma Global FZE et al. [read post]
3 Nov 2023, 7:15 am
The present case started as a claim for infringement brought by Astellas Pharma Inc (“Astellas”) against Teva and Sandoz (the “Defendants”). [read post]
10 Feb 2013, 4:00 pm
-based Astellas Pharma, a R&D-driven global pharmaceutical company. [read post]
